TMEM82
gene geneOn this page
Summary
TMEM82 (transmembrane protein 82, HGNC:32350) is a protein-coding gene on chromosome 1p36.21, encoding Transmembrane protein 82 (A0PJX8).
Predicted to be located in membrane.
Source: NCBI Gene 388595 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- MANE Select transcript:
NM_001013641
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32350 |
| Approved symbol | TMEM82 |
| Name | transmembrane protein 82 |
| Location | 1p36.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000162460 |
| Ensembl biotype | protein_coding |
| Entrez | 388595 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000375782, ENST00000465575, ENST00000853368
RefSeq mRNA: 1 — MANE Select: NM_001013641
NM_001013641
CCDS: CCDS30608
Canonical transcript exons
ENST00000375782 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001065415 | 15742835 | 15742907 |
| ENSE00001065417 | 15746867 | 15747054 |
| ENSE00001468363 | 15747546 | 15747982 |
| ENSE00001468365 | 15742499 | 15742647 |
| ENSE00003502888 | 15743020 | 15743194 |
| ENSE00003668792 | 15744160 | 15744580 |
Expression profiles
Bgee: expression breadth broad, 50 present calls, max score 92.56.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2198 / max 50.8453, expressed in 56 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 905 | 0.1938 | 44 |
| 906 | 0.0260 | 13 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 92.56 | gold quality |
| duodenum | UBERON:0002114 | 88.55 | gold quality |
| liver | UBERON:0002107 | 88.23 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.93 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 79.02 | gold quality |
| small intestine | UBERON:0002108 | 74.55 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 74.34 | gold quality |
| transverse colon | UBERON:0001157 | 70.39 | gold quality |
| kidney | UBERON:0002113 | 70.24 | gold quality |
| ascending aorta | UBERON:0001496 | 65.90 | gold quality |
| thoracic aorta | UBERON:0001515 | 65.89 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 64.97 | gold quality |
| right coronary artery | UBERON:0001625 | 61.55 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 60.99 | gold quality |
| intestine | UBERON:0000160 | 59.31 | gold quality |
| cortex of kidney | UBERON:0001225 | 58.51 | gold quality |
| rectum | UBERON:0001052 | 58.04 | gold quality |
| left coronary artery | UBERON:0001626 | 57.58 | gold quality |
| metanephros cortex | UBERON:0010533 | 56.82 | gold quality |
| colon | UBERON:0001155 | 53.96 | gold quality |
| popliteal artery | UBERON:0002250 | 51.13 | gold quality |
| tibial artery | UBERON:0007610 | 51.03 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.46 | gold quality |
| vermiform appendix | UBERON:0001154 | 47.23 | gold quality |
| body of stomach | UBERON:0001161 | 45.85 | gold quality |
| stomach | UBERON:0000945 | 44.55 | gold quality |
| fundus of stomach | UBERON:0001160 | 43.59 | gold quality |
| granulocyte | CL:0000094 | 42.80 | silver quality |
| gall bladder | UBERON:0002110 | 39.33 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 37.07 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.96 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting TMEM82, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-3922-5P | 98.77 | 66.53 | 1059 |
| HSA-MIR-4297 | 98.77 | 66.95 | 2013 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem82 | ENSDARG00000097606 |
| mus_musculus | Tmem82 | ENSMUSG00000043085 |
| rattus_norvegicus | ENSRNOG00000071385 |
Protein
Protein identifiers
Transmembrane protein 82 — A0PJX8 (reviewed: A0PJX8)
All UniProt accessions (1): A0PJX8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the TMEM82 family.
RefSeq proteins (1): NP_001013663* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031648 | TMEM82 | Domain |
Pfam: PF15816
UniProt features (14 total): transmembrane region 8, compositionally biased region 2, chain 1, sequence variant 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0PJX8-F1 | 77.61 | 0.30 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GSE45365_NK_CELL_VS_BCELL_DN, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN, chr1p36, MIKKELSEN_ES_ICP_WITH_H3K4ME3, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ZNF146_TARGET_GENES, ZNF85_TARGET_GENES, GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP, GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN, DESCARTES_MAIN_FETAL_HEPATOBLASTS, DESCARTES_FETAL_LIVER_HEPATOBLASTS, ZC3H11A_TARGET_GENES, CC2D1A_TARGET_GENES, GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
340 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM82 | FAM131C | Q96AQ9 | 578 |
| TMEM82 | SPATA3 | Q8NHX4 | 561 |
| TMEM82 | SLC25A34 | Q6PIV7 | 559 |
| TMEM82 | FBLIM1 | Q8WUP2 | 533 |
| TMEM82 | CCDC163 | A0A0D9SF12 | 530 |
| TMEM82 | CEP78 | Q5JTW2 | 521 |
| TMEM82 | CEP41 | Q9BYV8 | 492 |
| TMEM82 | SH3BP4 | Q9P0V3 | 492 |
| TMEM82 | CEP250 | Q9BV73 | 477 |
| TMEM82 | SNPH | O15079 | 471 |
| TMEM82 | OTOP2 | Q7RTS6 | 465 |
| TMEM82 | BEST4 | Q8NFU0 | 451 |
| TMEM82 | ZNF638 | Q14966 | 450 |
| TMEM82 | NTAN1 | Q96AB6 | 441 |
| TMEM82 | Q6GMV1 | Q6GMV1 | 434 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM82 | H2BC12L | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (4): TMEM82 (Two-hybrid), TMEM82 (Two-hybrid), CYP4F2 (Two-hybrid), LOC102724334 (Proximity Label-MS)
ESM2 similar proteins: A0JN53, A0PJX8, A1L1L2, A1L3T7, A4FV45, B0BMG8, E2JF22, G3HQ82, O15360, O43299, O70491, P60330, Q0KL00, Q0V8E7, Q17Q97, Q24JP3, Q3U829, Q49LS3, Q4QR83, Q562E7, Q5ND34, Q5R7B4, Q5T1A1, Q5XG04, Q6NUQ4, Q6PH58, Q6UX68, Q7L4E1, Q7Z412, Q8BGI5, Q8BM55, Q8BSD4, Q8BXV2, Q8C3R1, Q8C7B8, Q8IXR5, Q8K0R6, Q8N6S5, Q8R115, Q8VCA6
Diamond homologs: A0PJX8, B0BMG8, Q5XG04, Q8R115
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
673 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:15744576:GCAGG:G | donor_gain | 1.0000 |
| 1:15744579:GG:G | donor_gain | 1.0000 |
| 1:15744580:GG:G | donor_gain | 1.0000 |
| 1:15744581:G:GG | donor_gain | 1.0000 |
| 1:15744581:GTGA:G | donor_loss | 1.0000 |
| 1:15746865:A:AG | acceptor_gain | 1.0000 |
| 1:15746866:G:GA | acceptor_gain | 1.0000 |
| 1:15746866:GA:G | acceptor_gain | 1.0000 |
| 1:15746866:GAGGA:G | acceptor_gain | 1.0000 |
| 1:15742908:G:GG | donor_gain | 0.9900 |
| 1:15743018:A:AG | acceptor_gain | 0.9900 |
| 1:15743019:G:GG | acceptor_gain | 0.9900 |
| 1:15743019:GT:G | acceptor_gain | 0.9900 |
| 1:15743191:CAAG:C | donor_loss | 0.9900 |
| 1:15743192:AAGGT:A | donor_loss | 0.9900 |
| 1:15743193:AGGT:A | donor_loss | 0.9900 |
| 1:15743194:GG:G | donor_loss | 0.9900 |
| 1:15743195:GTG:G | donor_loss | 0.9900 |
| 1:15743196:T:A | donor_loss | 0.9900 |
| 1:15744578:AGG:A | donor_gain | 0.9900 |
| 1:15744579:GGG:G | donor_gain | 0.9900 |
| 1:15746865:A:AC | acceptor_loss | 0.9900 |
| 1:15746865:AGAG:A | acceptor_gain | 0.9900 |
| 1:15746866:GAGG:G | acceptor_gain | 0.9900 |
| 1:15742903:GCCAA:G | donor_gain | 0.9800 |
| 1:15743016:A:AG | acceptor_gain | 0.9800 |
| 1:15743016:AAAGT:A | acceptor_gain | 0.9800 |
| 1:15743017:A:G | acceptor_gain | 0.9800 |
| 1:15744577:CAGG:C | donor_gain | 0.9800 |
| 1:15744581:G:T | donor_gain | 0.9800 |
AlphaMissense
2134 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:15743153:T:C | F99L | 0.993 |
| 1:15743155:C:A | F99L | 0.993 |
| 1:15743155:C:G | F99L | 0.993 |
| 1:15744532:T:A | W237R | 0.982 |
| 1:15744532:T:C | W237R | 0.982 |
| 1:15744502:T:C | F227L | 0.981 |
| 1:15744504:C:A | F227L | 0.981 |
| 1:15744504:C:G | F227L | 0.981 |
| 1:15744479:C:A | A219D | 0.968 |
| 1:15742647:G:C | G30R | 0.966 |
| 1:15744542:T:A | L240H | 0.966 |
| 1:15744550:T:C | C243R | 0.966 |
| 1:15744548:T:A | I242N | 0.964 |
| 1:15744457:T:C | F212L | 0.963 |
| 1:15744459:T:A | F212L | 0.963 |
| 1:15744459:T:G | F212L | 0.963 |
| 1:15744530:T:C | F236S | 0.963 |
| 1:15743154:T:C | F99S | 0.961 |
| 1:15743150:G:A | E98K | 0.960 |
| 1:15744289:A:C | S156R | 0.959 |
| 1:15744291:C:A | S156R | 0.959 |
| 1:15744291:C:G | S156R | 0.959 |
| 1:15744529:T:C | F236L | 0.957 |
| 1:15744531:C:A | F236L | 0.957 |
| 1:15744531:C:G | F236L | 0.957 |
| 1:15744217:G:C | G132R | 0.953 |
| 1:15744503:T:G | F227C | 0.953 |
| 1:15744552:C:G | C243W | 0.950 |
| 1:15743151:A:T | E98V | 0.949 |
| 1:15742852:G:A | G36R | 0.947 |
dbSNP variants (sampled 300 via entrez): RS1000512368 (1:15742729 C>T), RS1000915865 (1:15740775 C>T), RS1002016956 (1:15742473 C>A), RS1002573247 (1:15745618 C>T), RS1002757512 (1:15741075 T>A,G), RS1002763163 (1:15745963 A>C,G), RS1002789745 (1:15745696 C>T), RS1003000983 (1:15741429 C>T), RS1003119108 (1:15746257 G>A), RS1003158082 (1:15741193 T>C), RS1003749981 (1:15742367 G>A), RS1003860316 (1:15741552 G>C), RS1004373841 (1:15746203 G>A), RS1004413266 (1:15746004 C>T), RS1005391388 (1:15742151 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_33 | Obesity-related traits | 2.000000e-06 |
| GCST004027_2 | Alcohol consumption (heavy vs. light/non-drinkers) | 2.000000e-07 |
| GCST004860_1 | Alcoholic chronic pancreatitis | 7.000000e-07 |
| GCST004860_107 | Alcoholic chronic pancreatitis | 2.000000e-06 |
| GCST004860_109 | Alcoholic chronic pancreatitis | 6.000000e-06 |
| GCST004860_134 | Alcoholic chronic pancreatitis | 1.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004626 | IGFBP-3 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| methyleugenol | decreases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Palmitic Acid | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.